Approved
consistent with clarifications in FDA memos of 4-19-02 and 6-5-02.
FDA will submit each individual survey under this clearance to OMB
and OMB will attempt to provide either approval or questions within
ten working days. The individual surveys won't serve as broader
surveys on consumer behavior, knowledge or attitudes except as they
pertain to the particular labeling issue at hand. As described in
in the 6-5-02, FDA will ensure adequate public input on the
individual surveys. Approval is for six months. In its next
submission, FDA will provide an evaluation of the use of this
generic clearance in support of its continuation.
Inventory as of this Action
Requested
Previously Approved
01/31/2003
01/31/2003
7,000
0
0
4,000
0
0
0
0
0
The purpose of these studies is to
help FDA formulate decisions and policies affecting the labeling of
conventional foods and dietary supplements. The objectives will be
to ascertain consumer understanding of labeling on fods and dietary
supplements and to identify the existing distribution of behavior,
knowledge, and attitudes in the populations that provides for
context for understanding such statements.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.